MS frailty study seeks clues in blood and balance

NCT ID NCT07521982

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will compare frailty, physical fitness, and levels of a hormone called irisin in 782 people with multiple sclerosis and healthy volunteers aged 18-65. Researchers will use tests like the Frailty Index, Berg Balance Scale, and 6-Minute Walk Test, along with blood samples. The goal is to better understand frailty in MS and guide future rehabilitation strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help identify biomarkers and targets for rehabilitation strategies to manage frailty in multiple sclerosis.

What could go wrong

This is an observational study, not a treatment trial. It will not directly improve health, and results may not lead to new therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPL SCLEROSİS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis Muscle Weakness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baskent University Alanya Hospital

    Antalya, Alanya, 07400, Turkey (Türkiye)

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••